Nasal spray recalled for microbial and yeast contamination nationwide
ReBoost nasal spray is recalled nationwide due to contamination with yeast, mold, and Achromobacter bacteria. All lot numbers within expiration are affected.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification requires a minimum score of 4 per the rubric. The product contains confirmed microbial contamination with no reported illnesses or injuries, placing it in the Severe range.
Plain-English summary
ReBoost nasal spray (0.68 fl. oz. bottles, NDC 62795-4005-9) is being recalled nationwide by Medinatura due to microbial contamination. The product contains yeast, mold, and the bacterium Achromobacter.
All lot numbers currently within expiration are affected by this recall, which applies to the entire United States. The manufacturer is Medinatura, located in Albuquerque, New Mexico.
Consumers who have purchased this product should discontinue use. Contact a healthcare provider if you have any health concerns after using this product.
The recalled product
- Product
- REBOOST (SILVER NITRATE,EUPHORBIA RESINIFERA RESIN, CALCIUM SULFIDE, GOLDENSEAL, POTASSIUM DICHROMATE,LUFFA OPERCULATA FRUIT, SODIUM CARBONATE, ECHINACEA UNSPECIFIED, CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE AND PULSATILLA VULGARIS)
- Brand
- REBOOST
- Manufacturer
- Medinatura New Mexico, inc.
- Category
- Drug — Nasal Spray
- Hazard
- microbial-contamination
- achromobacter
- yeast-mold
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry.
UPCs (1)
- 787647101863
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27